Polycystic ovary syndrome: pragmatic management across levels of care.
리뷰
1/5 보강
[OBJECTIVE] Polycystic ovary syndrome (PCOS) is a common endocrine condition requiring coordinated management across reproductive, metabolic, and psychological domains.
APA
Arshad A, Armeni E, et al. (2025). Polycystic ovary syndrome: pragmatic management across levels of care.. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 41(1), 2574874. https://doi.org/10.1080/09513590.2025.2574874
MLA
Arshad A, et al.. "Polycystic ovary syndrome: pragmatic management across levels of care.." Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, vol. 41, no. 1, 2025, pp. 2574874.
PMID
41220047 ↗
Abstract 한글 요약
[OBJECTIVE] Polycystic ovary syndrome (PCOS) is a common endocrine condition requiring coordinated management across reproductive, metabolic, and psychological domains. This narrative review explores pragmatic strategies that can be applied across levels of care, considering workforce capacity, referral thresholds, and patient access.
[METHODS] PubMed, Embase, and Ovid were searched (2000-2025) for guidelines, systematic reviews, clinical trials, and qualitative studies. Evidence was synthesised with attention to feasibility in primary versus secondary care.
[RESULTS] Menstrual irregularity can usually be managed in primary care with combined oral contraceptives or progestins, with referral for fertility or complex cases. Dermatological symptoms such as hirsutism and acne may require topical or hormonal therapy, with escalation to anti-androgens or dermatology input. Cardiometabolic and glycaemic risk should be screened routinely in general practice, with specialist referral for complex profiles. Emotional wellbeing-including anxiety, depression, eating disorders, and body image concerns-can be screened in primary care using validated questionnaires with onward referral as needed.
[CONCLUSIONS] Pragmatic PCOS care requires clear delineation between primary and specialist roles, integration of digital tools, and patient-centred education to reduce duplication, improve efficiency, and enhance outcomes.
[METHODS] PubMed, Embase, and Ovid were searched (2000-2025) for guidelines, systematic reviews, clinical trials, and qualitative studies. Evidence was synthesised with attention to feasibility in primary versus secondary care.
[RESULTS] Menstrual irregularity can usually be managed in primary care with combined oral contraceptives or progestins, with referral for fertility or complex cases. Dermatological symptoms such as hirsutism and acne may require topical or hormonal therapy, with escalation to anti-androgens or dermatology input. Cardiometabolic and glycaemic risk should be screened routinely in general practice, with specialist referral for complex profiles. Emotional wellbeing-including anxiety, depression, eating disorders, and body image concerns-can be screened in primary care using validated questionnaires with onward referral as needed.
[CONCLUSIONS] Pragmatic PCOS care requires clear delineation between primary and specialist roles, integration of digital tools, and patient-centred education to reduce duplication, improve efficiency, and enhance outcomes.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.